These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26395174)

  • 1. Fixed-Combination Olmesartan/Amlodipine Was Superior to Perindopril + Amlodipine in Reducing Central Systolic Blood Pressure in Hypertensive Patients With Diabetes.
    Ruilope LM;
    J Clin Hypertens (Greenwich); 2016 Jun; 18(6):528-35. PubMed ID: 26395174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fixed-dose combination of olmesartan/amlodipine was superior in central aortic blood pressure reduction compared with perindopril/amlodipine: a randomized, double-blind trial in patients with hypertension.
    Ruilope L; Schaefer A
    Adv Ther; 2013 Dec; 30(12):1086-99. PubMed ID: 24293132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Study of the Efficacy of Olmesartan/Amlodipine vs. Perindopril/Amlodipine in Peripheral and Central Blood Pressure Parameters After Missed Dose in Type 2 Diabetes.
    Redon J; Pichler G;
    Am J Hypertens; 2016 Sep; 29(9):1055-62. PubMed ID: 27220840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of triple antihypertensive therapy with the olmesartan/amlodipine/hydrochlorothiazide combination.
    Volpe M; Christian Rump L; Ammentorp B; Laeis P
    Clin Drug Investig; 2012 Oct; 32(10):649-64. PubMed ID: 22909147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study.
    Oparil S; Melino M; Lee J; Fernandez V; Heyrman R
    Clin Ther; 2010 Jul; 32(7):1252-69. PubMed ID: 20678674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study.
    Chrysant SG; Melino M; Karki S; Lee J; Heyrman R
    Clin Ther; 2008 Apr; 30(4):587-604. PubMed ID: 18498909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olmesartan/amlodipine/hydrochlorothiazide in participants with hypertension and diabetes, chronic kidney disease, or chronic cardiovascular disease: a subanalysis of the multicenter, randomized, double-blind, parallel-group TRINITY study.
    Kereiakes DJ; Chrysant SG; Izzo JL; Littlejohn T; Melino M; Lee J; Fernandez V; Heyrman R
    Cardiovasc Diabetol; 2012 Oct; 11():134. PubMed ID: 23110471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Sevikar® compared to the combination of perindopril plus amlodipine on central arterial blood pressure in patients with moderate-to-severe hypertension: Rationale and design of the SEVITENSION study.
    Ruilope LM; Schaefer A
    Contemp Clin Trials; 2011 Sep; 32(5):710-6. PubMed ID: 21586342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabetes.
    Redon J; Pichler G;
    J Hypertens; 2016 Feb; 34(2):359-67. PubMed ID: 26867060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of a single-pill versus free combination of perindopril/indapamide/amlodipine: a multicenter, randomized, double-blind study in Chinese patients with hypertension.
    Wang JG; Topouchian J; Bricout-Hennel S; Mu J; Chen L; Li P; He S; Luo S; Jiang W; Jiang Y; Sun Y; Zhang Y; Asmar R
    J Hypertens; 2024 Aug; 42(8):1373-1381. PubMed ID: 38660708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of fixed-dose amlodipine/olmesartan medoxomil with or without hydrochlorothiazide in Hispanic and non-Hispanic patients whose blood pressure is uncontrolled on antihypertensive monotherapy.
    Punzi H; Shojaee A; Maa JF;
    Ther Adv Cardiovasc Dis; 2012 Aug; 6(4):149-61. PubMed ID: 22855062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter, non-comparative study to evaluate the efficacy and safety of fixed-dose olmesartan/amlodipine in Korean patients with hypertension who are naïve or non-responders to anti-hypertensive monotherapy (ACE-HY study).
    Jung HW; Kim KI; Park CG; Kang DH; Ahn Y; Bae JH; Kim CH
    Clin Exp Hypertens; 2015; 37(6):482-9. PubMed ID: 25816197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Rakugi H; Ogihara T; Miyata Y; Sasai K; Totsuka N
    Clin Ther; 2012 Apr; 34(4):838-48. PubMed ID: 22440192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy/safety of a fixed-dose amlodipine/olmesartan medoxomil-based treatment regimen in hypertensive blacks and non-blacks with uncontrolled BP on prior antihypertensive monotherapy.
    Nesbitt S; Shojaee A; Maa JF
    J Clin Hypertens (Greenwich); 2013 Apr; 15(4):247-53. PubMed ID: 23551724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olmesartan improves pulse wave velocity and lowers central systolic blood pressure and ambulatory blood pressure in patients with metabolic syndrome.
    Raff U; Walker S; Ott C; Schneider MP; Schmieder RE
    J Clin Hypertens (Greenwich); 2015 Feb; 17(2):98-104. PubMed ID: 25537177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Fixed-Dose Perindopril Arginine/Amlodipine in Hypertensive Patients Not Adequately Controlled with Amlodipine 5 mg or Perindopril tert-Butylamine 4 mg Monotherapy.
    Hu D; Sun Y; Liao Y; Huang J; Zhao R; Yang K
    Cardiology; 2016; 134(1):1-10. PubMed ID: 26771522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of a fixed-dose combination of perindopril arginine/amlodipine on the level and variability of blood pressure according to its office visit-to-visit measurements and self-measurements at home: A subanalysis of the PREVOSHODSTVO (SUPERIORITY) program].
    Ostroumova OD
    Ter Arkh; 2017; 89(8):29-36. PubMed ID: 28914848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Open-label study assessing the long-term efficacy and safety of triple olmesartan/amlodipine/hydrochlorothiazide combination therapy for hypertension.
    Volpe M; de la Sierra A; Ammentorp B; Laeis P
    Adv Ther; 2014 May; 31(5):561-74. PubMed ID: 24760656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.